Yutaka Kawakami

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber et al. · Nature Medicine · 1998 · 1.8K citations

Medicine, Immunology, Oncology +16

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

Yutaka Kawakami, S Eliyahu, Kazuyasu Sakaguchi et al. · The Journal of Experimental Medicine · 1994 · 865 citations · Full text

Life Sciences, Immunology, Oncology +17

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

Nicholas P. Restifo, Franco Marincola, Yutaka Kawakami et al. · JNCI Journal of the National Cancer Institute · 1996 · 529 citations · Full text

Life Sciences, Immunology, Oncology +17

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.

Licia Rivoltini, Yutaka Kawakami, Kazushige Sakaguchi et al. · The Journal of Immunology · 1995 · 294 citations

Life Sciences, Immunology, Oncology +17

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen.

R F Wang, Maria R. Parkhurst, Yutaka Kawakami et al. · The Journal of Experimental Medicine · 1996 · 258 citations · Full text

Life Sciences, Immunology, Oncology +17